News13/05/2026
METiS TechBio lists after HongShan seed and follow-on investment
HongShan →HongShan reported METiS TechBio listing on Hong Kong Exchange, following an angel-plus investment in late 2019 and five investment rounds. Opening-price fund-recovery language is not stored as realized performance or IRR.